LIVEPERSON, INC. (LPSN) Scorecard
- 2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q4: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q3: Total return Lose; Revenue growth Lose; EPS growth Win.
56/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 1 wins, 11 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q20/3 |
LoseLPSN / S&P -25.49% / 15.20% |
LoseLPSN / S&P -15.77% / 15.00% |
LoseLPSN / S&P -50.25% / 50.40% |
| 2026-Q10/3 |
LoseLPSN / S&P -34.11% / -4.33% |
LoseLPSN / S&P -19.19% / 11.30% |
LoseLPSN / S&P -59.41% / 27.70% |
| 2025-Q40/3 |
LoseLPSN / S&P -55.52% / 2.65% |
LoseLPSN / S&P -22.00% / 9.00% |
LoseLPSN / S&P -42.28% / 13.40% |
| 2025-Q31/3 |
LoseLPSN / S&P -42.57% / 8.12% |
LoseLPSN / S&P -23.03% / 4.61% |
WinLPSN / S&P 16.64% / 13.45% |
| 2025-Q22/3 |
WinLPSN / S&P 26.25% / 10.94% |
LoseLPSN / S&P -24.89% / 4.83% |
WinLPSN / S&P 50.56% / 10.63% |
| 2025-Q11/3 |
LoseLPSN / S&P -47.37% / -4.27% |
LoseLPSN / S&P -23.04% / 4.98% |
WinLPSN / S&P 42.84% / 10.57% |
| 2024-Q42/3 |
WinLPSN / S&P 18.75% / 2.41% |
LoseLPSN / S&P -22.27% / 5.25% |
WinLPSN / S&P 27.37% / 6.15% |
| 2024-Q32/3 |
WinLPSN / S&P 120.69% / 5.89% |
LoseLPSN / S&P -21.97% / 5.89% |
WinLPSN / S&P 1568.53% / 6.11% |
| 2024-Q21/3 |
LoseLPSN / S&P -42.00% / 4.28% |
LoseLPSN / S&P -20.86% / 5.38% |
WinLPSN / S&P 1411.45% / 5.12% |
| 2024-Q11/3 |
LoseLPSN / S&P -73.61% / 10.56% |
LoseLPSN / S&P -22.91% / 5.71% |
WinLPSN / S&P 702.90% / 5.59% |
| 2023-Q41/3 |
LoseLPSN / S&P -2.57% / 11.69% |
LoseLPSN / S&P -21.91% / 6.81% |
WinLPSN / S&P 530.92% / 7.78% |
| 2023-Q30/3 |
LoseLPSN / S&P -13.94% / -3.27% |
LoseLPSN / S&P -16.88% / 7.52% |
LoseLPSN / S&P -54.02% / -5.03% |
| 2023-Q20/3 |
LoseLPSN / S&P 2.49% / 8.74% |
LoseLPSN / S&P -9.44% / 9.50% |
LoseLPSN / S&P -56.62% / -8.57% |
| 2023-Q11/3 |
LoseLPSN / S&P -56.51% / 7.50% |
LoseLPSN / S&P 0.07% / 10.77% |
WinLPSN / S&P 2.55% / -15.69% |
| 2022-Q42/3 |
WinLPSN / S&P 7.64% / 7.56% |
LoseLPSN / S&P 9.62% / 11.88% |
WinLPSN / S&P 68.89% / -17.99% |
| 2022-Q32/3 |
LoseLPSN / S&P -33.38% / -4.88% |
WinLPSN / S&P 15.22% / 13.47% |
WinLPSN / S&P 142.97% / -1.41% |
| 2022-Q22/3 |
LoseLPSN / S&P -42.10% / -16.10% |
WinLPSN / S&P 18.96% / 13.71% |
WinLPSN / S&P 117.27% / 11.04% |
| 2022-Q12/3 |
LoseLPSN / S&P -31.63% / -4.60% |
WinLPSN / S&P 24.09% / 15.97% |
WinLPSN / S&P 72.79% / 42.23% |
| 2021-Q41/3 |
LoseLPSN / S&P -39.41% / 11.03% |
WinLPSN / S&P 28.10% / 15.00% |
LoseLPSN / S&P 11.11% / 96.40% |
| 2021-Q31/3 |
LoseLPSN / S&P -6.78% / 0.58% |
WinLPSN / S&P 30.38% / 10.77% |
LoseLPSN / S&P -31.18% / 69.42% |
| 2021-Q22/3 |
WinLPSN / S&P 19.91% / 8.55% |
WinLPSN / S&P 31.02% / 6.58% |
LoseLPSN / S&P -17.75% / 51.81% |
| 2021-Q11/3 |
LoseLPSN / S&P -15.25% / 6.17% |
WinLPSN / S&P 30.71% / -1.06% |
LoseLPSN / S&P -24.02% / 7.39% |
| 2020-Q43/3 |
WinLPSN / S&P 19.70% / 12.15% |
WinLPSN / S&P 25.72% / -3.72% |
WinLPSN / S&P 5.88% / -33.42% |
| 2020-Q33/3 |
WinLPSN / S&P 25.49% / 8.93% |
WinLPSN / S&P 23.47% / -2.04% |
WinLPSN / S&P 55.00% / -27.10% |
| 2020-Q23/3 |
WinLPSN / S&P 82.11% / 20.54% |
WinLPSN / S&P 21.19% / -0.46% |
WinLPSN / S&P 85.71% / -27.11% |
| 2020-Q12/3 |
LoseLPSN / S&P -38.51% / -19.60% |
WinLPSN / S&P 17.56% / 3.47% |
WinLPSN / S&P 167.16% / -14.75% |
| 2019-Q42/3 |
LoseLPSN / S&P 3.64% / 9.07% |
WinLPSN / S&P 16.72% / 5.36% |
WinLPSN / S&P 264.29% / 2.99% |
| 2019-Q33/3 |
WinLPSN / S&P 27.32% / 1.70% |
WinLPSN / S&P 15.22% / 5.02% |
WinLPSN / S&P 215.79% / 0.21% |
| 2019-Q22/3 |
LoseLPSN / S&P -3.38% / 4.30% |
WinLPSN / S&P 14.34% / 6.64% |
WinLPSN / S&P 225.00% / 8.65% |
| 2019-Q13/3 |
WinLPSN / S&P 53.87% / 13.65% |
WinLPSN / S&P 14.06% / 8.12% |
WinLPSN / S&P 148.15% / 14.29% |
| 2018-Q42/3 |
LoseLPSN / S&P -27.32% / -13.52% |
WinLPSN / S&P 14.15% / 9.05% |
WinLPSN / S&P 35.48% / 18.23% |
| 2018-Q32/3 |
WinLPSN / S&P 22.99% / 7.71% |
WinLPSN / S&P 10.98% / 10.21% |
LoseLPSN / S&P -9.52% / 19.06% |
| 2018-Q21/3 |
WinLPSN / S&P 29.05% / 3.43% |
LoseLPSN / S&P 8.42% / 9.03% |
LoseLPSN / S&P -44.00% / 14.46% |
| 2018-Q11/3 |
WinLPSN / S&P 42.17% / -0.76% |
LoseLPSN / S&P 3.65% / 7.68% |
LoseLPSN / S&P -47.06% / 12.46% |
| 2017-Q40/3 |
LoseLPSN / S&P -15.13% / 6.64% |
LoseLPSN / S&P -1.75% / 7.03% |
LoseLPSN / S&P -32.61% / 13.82% |
| 2017-Q31/3 |
WinLPSN / S&P 23.18% / 4.48% |
LoseLPSN / S&P -3.64% / 5.68% |
LoseLPSN / S&P -36.36% / 17.57% |
| 2017-Q21/3 |
WinLPSN / S&P 60.58% / 3.09% |
LoseLPSN / S&P -7.08% / 4.83% |
LoseLPSN / S&P -5.66% / 17.74% |
| 2017-Q10/3 |
LoseLPSN / S&P -9.27% / 6.07% |
LoseLPSN / S&P -7.02% / 3.67% |
LoseLPSN / S&P 6.25% / 13.32% |
| 2016-Q40/3 |
LoseLPSN / S&P -10.23% / 3.82% |
LoseLPSN / S&P -6.79% / 2.09% |
LoseLPSN / S&P -2.13% / 7.05% |
| 2016-Q32/3 |
WinLPSN / S&P 32.65% / 3.85% |
LoseLPSN / S&P -5.16% / 0.20% |
WinLPSN / S&P 288.24% / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | LPSN total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -80.00% | 20.78% |
| Annualized return | -80.00% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | LPSN total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -99.71% | 83.14% |
| Annualized return | -68.98% | 12.86% |
10Y · 2016-09-01 to 2026-08-27
| Metric | LPSN total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -97.64% | 319.30% |
| Annualized return | -31.25% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.